IBM, Fenergo to Transform New Customer Onboarding for Financial Institutions | News

ARMONK, N.Y., Oct. 5, 2020 /PRNewswire/ — SIBOS: IBM (NYSE: IBM) and Fenergo, a leading provider of client lifecycle management (CLM) solutions for financial institutions, today announced the general availability of IBM Customer Lifecycle Management (CLM) with Fenergo. The offering is designed to incorporate artificial intelligence (AI) from IBM Watson and analytics on the IBM Cloud to help financial institutions drive efficiencies in customer onboarding through improved personalization, risk assessment and regulatory compliance.

Onboarding a new client can often take weeks for a financial institution to complete. Research undertaken by Forrester and Fenergo showed financial institutions that have implemented only partial onboarding solutions spend between two and 12 weeks to complete the new client onboarding process. Additionally, significant financial penalties and sanctions can follow if anti-money laundering (AML) and know-your-client (KYC) regulations are not followed.

The collaboration with Fenergo is one of many ways IBM is helping financial institutions reinvent the customer experience through digital transformation. Today, 9 out of 10 Fortune 500 banks and financial institutions use IBM Cloud, and IBM continues to help expand and strengthen its solution offerings, services and partnerships. IBM’s RegTech portfolio of solutions applies the latest advancements in AI, machine learning and automation to the risk and compliance process, increasing operational efficiency, accelerating insight and improving transparency, while running on a hybrid cloud. IBM also continues to invest in hybrid cloud ecosystems, particularly for the financial services industry. 

“Compliance can be time consuming and costly, often diverting resources from the core focus of improving the customer experience,” said Likhit Wagle, General Manager; Global Banking of IBM. “Artificial Intelligence is ideally suited to redefine how regulatory compliance is addressed, and IBM Watson is leading that effort. Through our strong ecosystem of partners, we’re helping to streamline these processes to allow banks, insurers

SEIPI, Malaysian counterparts to collaborate on sci-tech center

The Semiconductor and Electronics Industries in the Philippines Foundation, Inc. (SEIPI) said Friday it is collaborating with Malaysian industry associations to set up a science and technology center in the Philippines.

“We have met with several Malaysian organizations. The first one is SFAM (Semiconductor Fabrication Association of Malaysia),” SEIPI President Danilo C. Lachica said at an online conference.

He said the Malaysian group has agreed to help SEIPI with its plan to set up a science and technology center “to move the Philippines’ electronics industry up the value chain.”

“We will set up meetings with SFAM members and hopefully develop a memorandum of agreement on collaborative activities,” he added.

Mr. Lachica said the science and technology center is part of the industry’s road map funded by the Trade department and administered by the Science and Technology department.

“It’s called Product and Technology Holistic Strategy (PATHS)… We are looking for funding and technology partners like the Malaysian group,” he said.

Mr. Lachica also said SEIPI met with the Malaysian Integrated Chip Designer Association (MICDA) for “potential collaborative activities” concerning an integrated circuit (IC) design facility, outsourcing IC design and packaging activities, trade fairs, research and development, and localization.

He added SEIPI is also looking at a possible partnership with MIMOS Bhd., a Malaysian government-owned research and development center.

He said MIMOS can be a consultant or a partner for research and development work and microelectronics and technology transfer. — Arjay L. Balinbin

Source Article

Daily Mirror – OPPO Launches OPPO A53: Feel the Speed with OPPO’s Faster and Smoother A53 Smartphone

OPPO has launched the latest model of its A Series, the OPPO A53 in Sri Lanka. Designed to deliver a faster and smoother performance, A53 empowers users to feel the speed and connects to entertainment needs and friends. Available from October, 2020 in Sri Lanka A53 comes in two color options – Fancy Blue and Electric Black. A53 includes 4 GB Memory + 64 GB Storage and will be available for purchase at a retail price of LKR. 35,990.
Boasting a blazing-fast 90Hz refresh rate, OPPO A53 offers an immersive and smooth viewing experience with a 90Hz Neo-Display that offers a 90Hz refresh rate display and technology that rivals flagship phones. Whilst A53 has a 5000mAh Large Battery and 18W Fast Charge to keep the phone running longer, Qualcomm’s latest octa-core processor and OPPO’s first RAM+ Memory Optimization offers an all-around fast performance.

“In line with the promise of OPPO’s A Series, A53 continues to offer strong technology that introduces a fast and smooth mobile experience for our users. With the 90Hz Neo-Display, A53 offers a feature found on flagship-level smartphones, but still ensures long-lasting power, a faster performance, and an enhanced user experience that suit their everyday entertainment and communication needs”, said  Bob Li, CEO, Xinda Lanka (Pvt) Ltd (OPPO SriLanka).

A53 sports 4GB RAM and 64GB ROM, which can be expanded to 256GB through a 3-Card Slot, giving the flexibility to store as much as directly on to the phone.

A53’s large 6.5-inch HD+ screen, is accented by a single punch hole design that not only maximizes the screen’s real estate but also offers eye protection. 

To further elevate the mobile entertainment experience, A53 is equipped with a pair of Super Dual Speakers, which combined with Dirac 2.0 – the state-of-the-art digital sound correction technology that delivers

Zeiss’ full-frame Android camera is available to preorder for $6,000

The Zeiss ZX1, a unique camera that was announced more than two years ago before the company essentially stopped talking about it, may actually be in customers’ hands at some point in the near future. As noted by DPReview, B&H Photo has sent out emails saying that it’s coming soon and is now available to preorder for $6,000. It was originally supposed to be released in early 2019.

Why would anyone pay $6,000 for the ZX1? Well, it wouldn’t be wise to order without at least waiting for hands-on impressions of the finished product, but it is fair to say that it’s a one-of-a-kind camera. It has a 37-megapixel full-frame sensor, a fixed 35mm f/2 lens, an electronic viewfinder, and three dials to control aperture, shutter speed, and ISO. More unusually, it has a 4.3-inch touchscreen and runs a variant of Android, including a built-in version of Adobe Lightroom so you can edit right on the device itself. There’s also Wi-Fi, USB-C, and 512GB of onboard storage.

The obvious comparison would be with Sony’s RX1 compact cameras, which also feature full-frame sensors and Zeiss-branded 35mm f/2 lenses; the last one cost $3,300 in 2015. They don’t run Lightroom, of course, but they are a lot smaller. Another comparison in the premium full-frame compact space would be the Leica Q2, which sells for $4,995. Zeiss is no doubt confident in the ZX1’s optics and performance, but you know a camera’s expensive when it makes a Leica look cheap.

The value of the ZX1, then, will all come down to its UX and how effectively its software works. And, well, we don’t have any idea about that just yet. B&H Photo isn’t listing an actual release date, either, which means it’s possible that there’s still some way to go before it

Women In Longevity Medicine And The Rise Of The Longevity Physician

Over the past decade, we witnessed unprecedented advances in the field of biogerontology, and the massive convergence of biotechnology, information technology, AI, and medicine. And now we are witnessing the birth of a new field of longevity medicine, which integrates the latest advances in many of these fields of science and technology. My definition longevity medicine is advanced personalized preventative medicine powered by deep biomarkers of aging and longevity.

And, like in the field of AI for drug discovery, women are at the forefront of this revolution and there were precedents when we had to look for a male physician to make a conference panel more diverse. 

One of the physician-scientists who stands out in this area is Dr. Evelyne Yehudit Bischof. I first got a note with a request for more information on one of our research papers from Dr. Bischof on December 30th, 2019 while in Shanghai. A request I almost ignored due to the heavy workload but accidentally I looked at her profile which was highly unusual. In brief, Evelyne is a German medical doctor with an MD from Max Planck Institute for Molecular Biology and Genetics, who interned at Columbia University, and Harvard MGH and Beth Israel Medical Deaconess, attending physician at University Hospital Basel in Switzerland, and associate professor at Shanghai University of Medicine and Health Sciences.  She fluently spoke six languages including German, Russian, and Mandarin Chinese, which was quite impressive. The second time we met was at Human Longevity Inc, in San Diego when she was interviewing with one of the most influential entrepreneurs and investors in longevity biotechnology, Dr. Wei-Wu He to join HLI as a longevity physician.

The longevity